Joep Muijrers, Ph.D., is the Chief Financial Officer at PureTech Health, a publicly-traded biopharmaceutical company aiming to improve the lives of patients through the development of breakthrough medicine. Joep has two decades of experience in corporate and capital finance, specifically focused on investment, M&A and fundraising. Given his keen interest in sustainable drug development, Joep actively promotes cooperation between the different stakeholders in the healthcare/life sciences sector and he is a frequent keynote speaker and panelist. Prior to joining PureTech Health, he was a Portfolio Manager and Partner at LSP (Life Sciences Partners), a trans-Atlantic investor group with exclusive focus on healthcare/life sciences. At LSP, Joep was responsible for investing in publicly-traded companies, a strategy that generated a total return of more than 900% in a 10-year period (Q2 2008 - Q1 2018). Prior to joining LSP, he held the position of Director Corporate Finance and Capital Markets at Fortis Bank, currently part of ABN AMRO. Joep holds a Ph.D. degree in Molecular Biology from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany.